An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes

Neuron Glia Biology

Volumn 2, Issue 2, 2006, Pages 81-91

  Ma, Jianmei ^a,b   Matsumoto, Michio ^a,c   Tanaka, Kenji F ^a,c   Takebayashi, Hirohide ^a   Ikenaka, Kazuhiro ^a,c  

^a NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

Glial activation; Neuropathology; Oligodendrocyte; Oligodendrocyte progenitor; Proteolipid protein

Indexed keywords

MYELIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHRONIC DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; GENE; GENE OVEREXPRESSION; GLIA; IMMUNE MEDIATED INJURY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LATE ONSET CHRONIC DEMYELINATING DISEASE; MULTIPLE SCLEROSIS; MUTANT; MYELIN MEMBRANE LIKE STRUCTURE; MYELIN SHEATH; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; ONSET AGE; PLP GENE; PRIORITY JOURNAL; RELAPSE; REMISSION; REMYELINIZATION; TRANSGENIC ANIMAL; WHITE MATTER;

ANIMALIA;

EID: 33645500037     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1364/JOSAB.23.000081     Document Type: Article

References (31)

1. Antel J. and Bar-Or A. (2004) Multiple Sclerosis: Therapy. In Lazzarini R.A. (ed) Myelin Biology and Disorders, Vol. 2. Academic Press, pp. 791-806.
2. Antony J.M., van Marle G., Opii W., Butterfield D.A., Mallet F., Yong V.W. et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nature Neuroscience 7, 1088-1095.
3. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K. and Ting J.P. (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neuroscience 4, 1116-1122.
4. Ben-Nun A., Ron Y. and Cohen I.R. (1980) Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature 288, 389-390.
5. Carson M.J. (2002) Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40, 218-231.
6. Ding L., Takebayashi H., Watanabe K., Ohtsuki T., Tanaka K.F., Nabeshima Y. et al. (2005) Short-term lineage analysis of dorsally derived Olig3 cells in the developing spinal cord. Developmental Dynamics 234, 622-632.
7. Franklin R.J. (2002) Why does remyelination fail in multiple sclerosis? Nature Reviews Neuroscience 3, 705-714.
8. Inoue Y., Kagawa T., Matsumura Y., Ikenaka K. and Mikoshiba K. (1996) Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neuroscience Research 25, 161-172.
9. Kagawa T., Ikenaka K., Inoue Y., Kuriyama S., Tsujii T., Nakao J. et al. (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13, 427-442.
10. Kim Y.S. and Kim S.U. (1991) Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. Journal of Neuroscience Research 29, 100-106.
11. Kotter M.R., Zhao C., van Rooijen N. and Franklin R.J. (2005) Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiology of Disease 18, 166-175.
12. Levine S. (1986) A relapsing form of allergic encephalomyelitis in rats due to enhanced absorption of inoculum. Journal of Neuropathology and Experimental Neurology 45, 247-257.
13. Li W.W., Setzu A., Zhao C. and Franklin R.J. (2005) Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. Journal of Neuroimmunology 158, 58-66.
14. Lu Q.R., Yuk D., Alberta J.A., Zhu Z., Pawlitzky I., Chan J. et al. (2000) Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25, 317-329.
15. Lubetzki C., Williams A., and Stankoff B. (2005) Promoting repair in multiple sclerosis: problems and prospects. Current Opinion in Neurology 18, 237-244.
16. Ludwin S.K. (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Laboratory Investigation 39, 597-612.
17. Mason J.L., Suzuki K., Chaplin D.D. and Matsushima G.K. (2001) Interleukin-ibeta promotes repair of the CNS. The Journal of Neuroscience 21, 7046-7052
18. Mason J.L., Xuan S., Dragatsis I., Efstratiadis A. and Goldman J.E. (2003) Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. The Journal of Neuroscience 23, 7710-7718.
19. Ohgoh M., Hanada T., Smith T., Hashimoto T., Ueno M., Yamanishi Y. et al. (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 125, 170-178.
20. Plant S.R., Arnett H.A. and Ting J.P. (2005) Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. Glia 49, 1-14.
21. Pringle N.P., Mudhar H.S., Collarini E.J. and Richardson W.D. (1992) PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115, 535-551.
22. Raivich G., Gehrmann J. and Kreutzberg G.W. (1991) Increase of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor receptors in the regenerating rat facial nucleus. Journal of Neuroscience Research 30, 682-686.
23. Readhead C., Schneider A., Griffiths I. and Nave K.A. (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12, 583-595.
24. Simons M., Kramer E.M., Macchi P., Rathke-Hartlieb S., Trotter J., Nave K.A. et al. (2002) Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications tor Pelizaeus-Merzbacher disease. Journal of Cell Biology 157, 327-336.
25. Sommer I. and Schachner M. (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Developmental Biology 83, 311-327.
26. Southwood C. and Gow, A. (2001) Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene. Microscopy Research and Technique 52, 700-708.
27. Takebayashi H., Yoshida S., Sugimori M., Kosako H., Kominami R., Nakafuku M. et al. (2000) Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mechanisms of Development 99, 143-148.
28. Talbott J.F., Loy D.N., Liu Y., Qiu M.S., Bunge M.B., Rao M.S. et al. (2005) Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Experimental Neurology 192, 11-24.
29. Tanaka K. (1993) Cloning and expression of a glutamate transporter from mouse brain. Neuroscience Letters 159, 183-186.
30. Yamamura T., Konola J.T., Wekerle H. and Lees M.B. (1991) Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. Journal of Neurochemistry 57, 1671-1680.
31. Zhou Q., Wang S. and Anderson D.J. (2000) Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25, 331-343.